Ireland· IE-PA-PA0736/034/001
Gelaspan Solution for Infusion
A gelatine product containing succinylated gelatine (= modified fluid gelatine) + sodium chloride + sodium acetate trihydrate + potassium chloride, registered in Ireland by B. Braun Melsungen AG. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Gelatine is registered in 9 of 19 countries.
Countries holding a registration under ATC B05AA06 (gelatine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Gelatine · ATC B05AA06
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Succinylated gelatine (= modified fluid gelatine) + Sodium chloride + Sodium acetate trihydrate + Potassium chloride
- Manufacturer
- B. Braun Melsungen AG
- Country
- Ireland (IE)
- ATC code
- B05AA06
- ATC class
- Gelatine
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0736/034/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AA06
Gelatine, as other registers publish it.
- PolandGelaspanB. Braun Melsungen AG
- NorwayGelaspanB. Braun Melsungen AG
- DenmarkGelaspanB. Braun Melsungen
- FinlandGelaspanB. Braun Melsungen AG
- CzechiaGELASPAN 4%B. Braun Melsungen AG, Melsungen
- CzechiaGELASPAN 4%B. Braun Melsungen AG, Melsungen
- NetherlandsGelaspan, oplossing voor infusieB. Braun Melsungen AG (Melsungen)
- FinlandGelifundol SOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9afd4958-ecf6-401f-8e0f-4c166b59528a GET /v1/drugs/9afd4958-ecf6-401f-8e0f-4c166b59528a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05AA",
"B05AA06"
],
"strength": null,
"pa_number": "PA0736/034/001",
"substances": [
"Succinylated gelatine (= modified fluid gelatine)",
"Sodium chloride",
"Sodium acetate trihydrate",
"Potassium chloride",
"Calcium chloride dihydrate",
"Magnesium chloride hexahydrate"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "09/09/2011",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about gelatine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.